Mitoxantrone and ifosfamide as second-line therapy of epithelial ovarian cancer. A pilot study by the I.T.M.O. Group.
Di Leo
A
A
Bajetta
E
E
Biganzoli
L
L
Bohm
S
S
Lupi
G
G
Oriana
S
S
Riboldi
G
G
Spatti
G
G
Zunino
F
F
Di Re
F
F
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010865:Pilot Projects; D016896:Treatment Outcome
D008942:Mitoxantrone; D007069:Ifosfamide